Moni Roy

Cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in advanced ovarian cancer: a randomized phase III study of the National Cancer Institute of Canada Clinical Trials Group.

K. Swenerton, J Jeffrey, Gavin Stuart et al. · Journal of Clinical Oncology · 1992 · 214 citations

Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer: outcomes in the partially platinum-sensitive (platinum-free interval 6–12 months) subpopulation of OVA-301 phase III randomized trial

Andrés Poveda, Ignace Vergote, Sergei Tjulandin et al. · Annals of Oncology · 2010 · 168 citations · Full text

Cyclin C is a haploinsufficient tumour suppressor

Na Li, Anne Fassl, Joel M. Chick et al. · Nature Cell Biology · 2014 · 154 citations · Full text

Oncology, Medicine, Cyclin C +5

Spontaneous and induced mutations in a single open reading frame alter both virulence and avirulence in Xanthomonas campestris pv. vesicatoria avrBs2

Kathy Swords, Douglas Dahlbeck, Brian Kearney et al. · Journal of Bacteriology · 1996 · 142 citations · Full text

Biology, Bs2 Pepper, Induced Mutations +14

Lymph node metastases in low-grade endometrial stromal sarcoma

Julie Riopel, Marie Plante, Marie‐Claude Renaud et al. · Gynecologic Oncology · 2004 · 94 citations

Medicine, Surgical Pathology, Histopathology +4